Latest Headlines

Latest Headlines

Bayer's Grants4Apps accelerator funds its second crop of digital health startups

Germany's pharma bigwig Bayer kicked off its Grants4Apps accelerator. It will provide up to €50,000 (roughly $58,000) to 5 nascent med tech players, including one in China and two in Europe, where VC funding for digital health startups is 40 times lower than it is stateside.

Finding the Fierce: A call for nominations of the top women in med tech

Last year, FierceMedicalDevices debuted its list of top women in med tech. This year we'd like to make it even better. Please let us know who the most important women are in med tech, including medical devices and diagnostics.

Bayer sees 'enormous' advantage in treating both crops and humans

Drugmakers such as Novartis and Sanofi long ago bowed out of the crop science field, bidding farewell to their units to focus their attention on pharma. But the way Bayer sees it, the area is an important piece of the life sciences puzzle.

Bayer's bets on consumer health deliver during Q2

Bayer CEO Marijn Dekkers bet that picking up Merck's consumer business last year would give his company a boost as it prepares to hive off its plastics unit and refocus on life sciences. Now Dekkers' gamble appears to be paying off, as the Leverkusen-based drugmaker beat analysts' estimates in Q2 with the help of its new consumer business and recent launches.

Papal visit coincides with FDA panel meeting for Bayer's Essure, riles advocates

Last month, the FDA scheduled a September panel meeting to take a hard look at Bayer's controversial birth control device, Essure, after getting complaints of clinical trial fraud and serious side effects tied to the product. Now, the agency is facing more pushback from women campaigning against the device, who claim that regulators purposely selected the panel meeting date to coincide with a visit from the pope.

Bayer homes in on €10B plastics IPO with plans for summer roadshow

Bayer is gearing up to spin off its plastics unit and become a life-sciences-focused company, and as part of that prep, it's going on an investor roadshow to seek feedback on its plans.

Top 10 pharma companies in social media

Social media success in consumer marketing has advanced beyond counting fans and followers. Today it's all about shares, retweets and links that indicate real consumer engagement with brands....

FDA approves a second placement confirmation test for Bayer's controversial Essure birth control device

It may be too little too late. But now the FDA has signed off on the use of transvaginal ultrasound as a means of ensuring the proper placement of the Essure permanent birth control device within three months of its insertion.

Bayer draws up big sales plans for ex-Merck OTC meds

Bayer has said it can pump an extra $400 million in revenue out of the OTC portfolio it acquired from Merck last year. And with that target in mind, new launches are on the agenda.

Bayer, J&J aim to protect Xarelto's market lead with focus on clinical data

Bayer and Johnson & Johnson know that right now, there's an impression out there that rival drug Eliquis--from Pfizer and Bristol-Myers Squibb--is superior to their next-gen clot-fighter Xarelto, despite their drug's market-share lead.